Haselmeier GmbH develops, manufactures and distributes injection devices for pharmaceutical and biotech companies for subcutaneous administration of medications. The product offering targets manufacturers of innovative pharma and biotech products as well as providers of material‑intensive biosimilars; the company explicitly cites the product platform "D‑Flex." The company is part of the medmix Group and generates over 50% of its revenues with one main customer. During the year it was decided to relocate production to subsidiaries in India and the Czech Republic and to close the Buchen plant as of June 30, 2025.
Die Fertigung und der Vertrieb von medizinischen Geräten.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 20200 (as of 20 November 2026)
| Name | Type | City |
|---|---|---|
| Carina Feldmann | Geschäftsführer(in) | Schluchsee |
| Sabine Hufschmitt | Geschäftsführer(in) | Ostelsheim |
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 20200 (as of 20 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 27.09.2023 | Registered Seat Change | Neue |
| 27.09.2023 | Business Address Change | Schelmenwasenstraße 14, 70567 Stuttgart |
| 27.09.2023 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 28.05.2009 | Capital Increase | +2.000.000 € | 2.027.700 € |
| 07.10.2005 | Share Capital Set | — | 27.700 € |
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 20200 (as of 20 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | €39,339,083 | -€1,823,598 | €44,147,456 | 100 |
| 2024 | €47,537,050 | -€9,546,096 | €51,880,833 | 140 |
| 2023 | €17,421,546 | €861,268 | €49,087,290 | 160 |
| 2022 | €43,112,864 | -€2,476,237 | €33,264,988 | 121 |
| 2021 | €35,796,222 | -€2,477,306 | €34,388,445 | 118 |
| 2020 | €16,918,851 | -€1,998,531 | €36,797,441 | 98 |
| 2019 | €9,335,466 | -€4,999,318 | €9,345,139 | 88 |
| 2018 | €11,227,665 | €1,025,952 | €13,847,414 | 79 |
| 2017 | €11,241,890 | -€518,079 | €12,598,265 | 83 |
| 2016 | €12,137,617 | -€204,813 | €13,093,863 | 92 |
Source: German Company Register (Unternehmensregister) · Annual accounts
Sign in to download data
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 20200 (as of 20 November 2026)
GEA Lyophil GmbH
Elsdorf · Herstellung von allen anderen Maschinen für sonstige bestimmte Wirtschaftszweige a. n. g.
MAVIG GmbH
München · Herstellung von medizinischen und zahnmedizinischen Apparaten und Materialien a. n. g.
SCHMITZ medical GmbH
Wickede · Herstellung von medizinischen und zahnmedizinischen Apparaten und Materialien a. n. g.